Who owns TELIX PHARMACEUTICAL LTD SPONSORED?
- Ticker: TLX
- CUSIP Number: 87961m105
Tip: Access positions for across all investors
Analyze quarterly positions in Telix Pharmaceutical Ltd Sponsored with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Telix Pharmaceutical Ltd Sponsored stock
Who bought or sold TELIX PHARMACEUTICAL LTD SPONSORED this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| FMR | 565k | $5.4M | 357% | Mar 2026 |
|
| Portolan Capital Management | 541k | $5.2M | 100% | Mar 2026 |
|
| Lazard Asset Management | 290k | $2.8M | 16% | Mar 2026 |
|
| Portland Investment Counsel | 266k | $2.5M | 0% | Mar 2026 |
|
| Private Advisor | 174k | $1.7M | 276% | Mar 2026 |
|
| Integrated Wealth Concepts | 164k | $1.6M | 100% | Mar 2026 |
|
| Hennion & Walsh Asset Management | 150k | $1.7M | 100% | Jun 2026 |
|
| Raiffeisen Bank International | 130k | $1.2M | 100% | Mar 2026 |
|
| Morgan Stanley | 116k | $1.1M | 560% | Mar 2026 |
|
| Mariner Wealth Advisors | 43k | $415k | 19% | Mar 2026 |
|
| Capricorn Fund Managers | 36k | $416k | 100% | Jun 2026 |
|
| Schonfeld Strategic Advisors | 35k | $334k | 100% | Mar 2026 |
|
| JustInvest | 33k | $318k | 83% | Mar 2026 |
|
| UBS Group | 32k | $309k | 1545% | Mar 2026 |
|
| XTX Topco | 26k | $249k | 120% | Mar 2026 |
|
| IHT Wealth Management | 25k | $240k | -1% | Mar 2026 |
|
| Vident Advisory | 17k | $159k | -39% | Mar 2026 |
|
| XY Capital | 13k | $120k | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 12k | $115k | 700% | Mar 2026 |
|
| Bank of America Corporation | 10k | $96k | 100% | Mar 2026 |
|
| Rhumbline Advisers | 9.8k | $94k | -9% | Mar 2026 |
|
| Goss Wealth Management | 1.9k | $18k | 0% | Mar 2026 |
|
| CWM | 1.4k | $14k | 100% | Mar 2026 |
|
| EverSource Wealth Advisors | 956.00 | $11k | -48% | Jun 2026 |
|
| Larson Financial Group | 899.00 | $8.6k | 100% | Mar 2026 |
|
| Advisor Group Holdings | 756.00 | $7.2k | 141% | Mar 2026 |
|
| Ronald Blue Trust | 742.00 | $7.1k | -76% | Mar 2026 |
|
| Aspect Partners | 401.00 | $4.6k | 6% | Jun 2026 |
|
| BlackRock | 352.00 | $3.4k | 300% | Mar 2026 |
|
| GAMMA Investing | 278.00 | $3.2k | 100% | Jun 2026 |
|
| Basecamp Wealth Advisors | 276.00 | $2.6k | 0% | Mar 2026 |
|
| Assetmark | 185.00 | $2.1k | 21% | Jun 2026 |
|
| Signature | 148.00 | $1.7k | 100% | Jun 2026 |
|
| CVA Family Office | 127.00 | $1.2k | 100% | Mar 2026 |
|
| SRS Capital Advisors | 125.00 | $9.9k | -88% | Mar 2026 |
|
| MV Capital Management | 75.00 | $864.997500 | 23% | Jun 2026 |
|
| Bell Investment Advisors | 70.00 | $669.998000 | 100% | Mar 2026 |
|
| NISA Investment Advisors | 65.00 | $621.998000 | 100% | Mar 2026 |
|
| Smartleaf Asset Management | 37.00 | $332.001000 | -49% | Mar 2026 |
|
| Transamerica Financial Advisors | 28.00 | $266.999600 | 12% | Mar 2026 |
|
| Bogart Wealth | 26.00 | $300.001000 | 100% | Jun 2026 |
|
| Farther Finance Advisors | 14.00 | $161.000000 | 56% | Jun 2026 |
|
| Parallel Advisors | 1.00 | $13.000000 | -92% | Mar 2026 |
|
Who sold out of Telix Pharmaceutical Ltd Sponsored?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Marshall Wace | Dec 2025 | 47k | $350k |
| Jane Street | Dec 2025 | 40k | $300k |
| Quadrature Capital | Dec 2025 | 37k | $276k |
| Citadel Advisors | Dec 2025 | 23k | $172k |
| Millennium Management | Dec 2025 | 20k | $148k |
| Point72 Asset Management | Dec 2025 | 18k | $138k |
| Old Mission Capital | Dec 2025 | 15k | $111k |
| Independence Bank of Kentucky | Dec 2025 | 66.00 | $493.996800 |